ReachRxResearch
Home
Research
Sign Up
Ocular toxoplasmosis in the immunocompromised patient
Back to Research Hub
  1. Home
  2. Research Hub
  3. Ocular toxoplasmosis in the immunocompro…

Ocular toxoplasmosis in the immunocompromised patient

Progress in Retinal and Eye Research·September 1Open Access
OphthalmologySafety signalOcular ToxoplasmosisPosterior UveitisSystematic ReviewAntiparasiticMixedPyrimethamineSulfadiazineTrimethoprim-Sulfamethoxazole

Summary

View source

What was studied

A systematic review of the clinical course, diagnosis, and management of ocular toxoplasmosis in immunocompromised patients, synthesizing 276 cases from 109 published reports alongside epidemiological and immunological studies.

Key findings

Visual outcomes in immunocompromised patients with ocular toxoplasmosis are frequently poor; atypical presentations are common, and in over half of reported cases the diagnosis was initially missed.

Study limitations

Data are compiled from case reports and small series rather than prospective cohorts, introducing selection bias; the heterogeneity of immunocompromising conditions limits generalizability; and reliance on published literature may underrepresent mild or rapidly fatal cases.

Clinical implications

Clinicians should maintain a high index of suspicion for ocular toxoplasmosis in any immunocompromised patient with posterior uveitis, even when the presentation is atypical, as delayed diagnosis is common and contributes to poor visual outcomes. Early diagnostic workup and prompt management are essential to limit ocular and systemic complications.

Caveats

  • All clinical data are derived from published case reports and series (109 reports), which are inherently subject to publication bias and may not reflect the true spectrum of disease in immunocompromised populations
  • Over half of cases had an initial missed diagnosis, suggesting the reported sample may skew toward more severe or complex presentations
  • The immunocompromising conditions included are heterogeneous (e.g., HIV/AIDS, organ transplant, congenital immunodeficiency, iatrogenic immunosuppression), making it difficult to draw condition-specific conclusions

Related Questions

Explore related topics

How does HIV immunocompromise affect the severity and treatment outcomes of ocular toxoplasmosis?What diagnostic tools are most reliable for ocular toxoplasmosis in immunosuppressed patients?What are the recommended treatment regimens for ocular toxoplasmosis in transplant recipients or patients on biologics?

Publication Details

Year
2026
Journal
Progress in Retinal and Eye Research
Sample Size
n=276
Source
View article
Keep scrolling
More content below.
Up Next